|
Volumn 21, Issue 5, 2000, Pages 405-408
|
Efficacy of bromocriptine in the treatment of metastatic breast cancer- and prostate cancer-related hyperprolactinemia
a a a a a a a a |
Author keywords
Breast cancer; Hyperpolactinemia; Prolactin; Prostate cancer
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BROMOCRIPTINE;
CORTICOSTEROID;
DOPAMINE RECEPTOR;
DOPAMINE RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
LONG ACTING DRUG;
OPIATE;
PROLACTIN;
ADULT;
ADVANCED CANCER;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
AUTOCRINE EFFECT;
BLOOD ANALYSIS;
BREAST CANCER;
CANCER CELL;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
DRUG EFFICACY;
FEMALE;
HUMAN;
HYPERPROLACTINEMIA;
MALE;
METASTASIS;
PROGNOSIS;
PROLACTIN BLOOD LEVEL;
PROLACTIN RELEASE;
PROSTATE CANCER;
RADIOIMMUNOASSAY;
|
EID: 0033785634
PISSN: 0172780X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (12)
|